Patient had a known LV thrombus for which he was being anticoagulated prior to this admission, but in the setting of chemotherapy as well as nosebleeds, the patient had not been anticoagulated.
As the patient's counts had eventually come up, Heparin drip was initiated.
Patient was continued on his cardiac medications including aspirin, beta-blocker, and ACE inhibitor.
Patient was also transitioned eventually to Coumadin prior to discharge, and eventually the Heparin drip was stopped when the patient's INR was above 2.
Patient also had not been receiving his outpatient dose Lasix and after receiving fluids for several weeks, was in slightly worsening failure and prior to discharge was diuresed Lasix, to which he responded well and with improvement in his O2 saturations.
Infectious disease issues:  Patient on transfer to the unit remained on double antibiotic coverage with Levaquin and ceftriaxone as well as double fungal coverage with AmBisome and caspofungin.
His respiratory status improved to the point, where he required no oxygen and in consultation with the Infectious Disease service, who closely followed the patient, patient was eventually tapered to only Voriconazole and Levaquin, and by the time of discharge, patient was only on Voriconazole and will continue this on discharge until followup with [**First Name8 (NamePattern2) **] [**Doctor Last Name 3115**] of Infectious Disease service.
They were continued, and the patient will likely undergo at least one month total of Voriconazole treatment and more if he becomes neutropenic.
Patient was also continued on prophylactic acyclovir and Bactrim while in-house.
Splenic infarct:  Patient had pain from his infarct and initially was on Dilaudid PCA.
The patient is only on OxyContin 10 p.o.
and has not required extra pain medications.
Psychiatry did see the patient on [**2173-4-7**] and found him to have capacity to make decisions and in fact to have a remarkably good affect and insight given his complicated and nearly life threatening hospital course.
Lymphoma:  Patient did not receive further hyper-CVAD while in the hospital due to instability.
The patient did receive one dose of Rituxan on [**2173-4-2**].
The patient will follow up with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], the primary oncologist for further discussion of treatment for his lymphoma.
Patient has required occasional blood transfusions to keep his hematocrit above 30 secondary to his coronary artery disease.
Acyclovir 400 mg t.i.d.
Zestril 40 mg q.d.
Lopressor 25 mg b.i.d.
Imdur 30 mg q.d.
Lasix 20 mg q.d.
Enteric-coated aspirin 325 q.d.
Digoxin 0.125 q.d.
Folic acid 1 mg q.d.
Protonix 40 mg q.d.
Coumadin 2.5 mg h.s.
OxyContin 10 mg q.d., hold if patient not having further abdominal pain.
